Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Danske Bank and SEB in relation to Raketech’s listing on Nasdaq First North Premier
Mandate

Vinge advises Danske Bank and SEB in relation to Raketech’s listing on Nasdaq First North Premier

June 20, 2018 Capital Markets and Public M&A

Vinge advises Danske Bank A/S, Danmark, Sverige Filial and Skandinaviska Enskilda Banken (publ) who are acting as Joint Global Coordinators and Joint Bookrunners in connection with the listing of Raketech Group Holding plc – a marketing actor whose primary business involves using its online products to influence iGaming market users who are interested in sports and gambling and to guide them towards the best gambling services – on Nasdaq First North Premier. 

A prospectus was published on 18 June 2018 and the first day of trading on Nasdaq First North Premier is 29 June 2018. The total value of the offering amounts to between approx. SEK 530-550 million, assuming that the over-allotment option is exercised in full.
 
Vinge’s team consist mainly of David Andersson, Amanda Knutsson, Rikard Lindahl and Stephanie Stiernstedt.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026